Evaxion Biotech (EVAX) Tops Q3 EPS by 3c

Evaxion Biotech (NASDAQ: EVAX) reported Q3 EPS of ($0.24), $0.03 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Goldman "broadly" raises estimates for LTL and truckload stocks
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth